SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 204.63-1.1%12:01 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (20991)5/17/1998 8:06:00 PM
From: John O'Neill  Read Replies (1) of 32384
 
I believe the patent would be contested once a company starts selling the product. I guess, if Roche wanted to, they could sue for patent infringement after FDA approval and selling of Panretin by LGND. Sounds like Roche would also be taking on LLY in this, if they chose to pursue the matter.

JO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext